References

  1. Van de Donk NWCJ, Lokhorst HM, Anderson KC, Richardson PG. How I treat plasma cell leukemia. Blood. 2012; 120(12): 2376-2387. PubMed | Google Scholar

  2. Garcia-Sanz R, Orfao A, Gonzalez M, Tabernero MD, Blade J, Moro M J et al. Primary Plasma Cell: clinical, Immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood. 1999; 93(3): 1032-1037. PubMed | Google Scholar

  3. Kar R, Priyadarshmini S G, Niraimathi M, Basu D, Badhe B A. Clinico-pathological spectrum of primary plasma cell leukemia diagnosed at a tertiary care centre in south Indian over 5 year period. Indian J Hematol Blood Transf. 2012; 28(3): 170-174. PubMed | Google Scholar

  4. Talamo G, Dolloff NG, Sharma K, Zhu J, Malysz J. Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents. Rare Tumors. 2012; 4(3): e39. PubMed | Google Scholar

  5. Tembhane PR, Subramanian PG, Seghal K, Yajamanam B, Kumar A, Gadge V et al. Immunophenotypic profile of plasma cell leukemia: a retrospective study in a reference cancer center in indian and review of literature. Pathology et microbiology. 2011; 54(2): 294-298. PubMed | Google Scholar

  6. Rodriguez C, Pont JC, Gouin-Thibault I. La leucémie a plasmocytes. Ann Biol Clin. 2005; 63(5): 535-9. PubMed | Google Scholar

  7. Avet-Loiseau H, Daviet A, Brigaudeau C, Callet-Bauchu E, Terre C, Lafage-Pochitaloff M et al. Cytogenetic, interphase and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on belhaf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytognetique Hematologique. Blood. 2001; 97(3): 822-5. PubMed | Google Scholar